Ultragenyx EVP sells 1,899 shares in open trade
Ultragenyx Pharmaceutical Inc. executive Karah Herdman Parschauer reported an open-market sale of 1,899 shares of common stock at $24.62 per share.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Ultragenyx Pharmaceutical Inc. executive Karah Herdman Parschauer reported an open-market sale of 1,899 shares of common stock at $24.62 per share. After this transaction, she directly holds 94,462 shares. Her holdings include 646 shares acquired under the company’s Employee Stock Purchase Plan and previously reported RSU-based common stock that remains subject to vesting conditions.
Insider Trade Summary 10b5-1
Net Seller: 1,899 shares
Net Sell
1 txn
Insider
Parschauer Karah Herdman
Role
EVP and Chief Legal Officer
Sold
1,899 shs ($47K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,899 | $24.62 | $47K |
Holdings After Transaction:
Common Stock — 94,462 shares (Direct)
Footnotes (2)
- F1. Includes 646 shares acquired under the Company's Amended and Restated Employee Stock Purchase Place on April 30, 2026
- F2. Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Key Figures
Shares sold: 1,899 shares
Sale price: $24.62 per share
Shares held after transaction: 94,462 shares
+1 more
4 metrics
Shares sold
1,899 shares
Open-market sale on 2026-06-15
Sale price
$24.62 per share
Open-market transaction
Shares held after transaction
94,462 shares
Direct ownership following sale
ESPP shares included
646 shares
Acquired under Employee Stock Purchase Plan on 2026-04-30
Key Terms
open-market sale, Employee Stock Purchase Plan, RSUs, vesting conditions
4 terms
open-market sale financial
"reported an open-market sale of 1,899 shares of common stock at $24.62"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Employee Stock Purchase Plan financial
"Includes 646 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
RSUs financial
"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
vesting conditions financial
"underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions"
Vesting conditions are the rules that determine when someone earning company stock or stock options actually gains the right to keep or sell them, typically based on staying with the company for a set time or meeting performance targets. Think of it like keys that unlock gradually — some unlock by calendar date, others only after agreed milestones. Investors care because vesting shapes management incentives, the timing of share sales, and the number of shares that can enter the market, which can affect a company's valuation and ownership mix.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Ultragenyx (RARE) report for Karah Herdman Parschauer?
Ultragenyx reported that EVP and Chief Legal Officer Karah Herdman Parschauer sold 1,899 shares of common stock in an open-market transaction. This Form 4 filing details the sale and her updated share ownership position after the transaction.
What role does the insider hold at Ultragenyx (RARE) in this Form 4 filing?
The reporting person, Karah Herdman Parschauer, serves as Ultragenyx’s EVP and Chief Legal Officer. Her position as a senior officer makes her equity transactions subject to Form 4 reporting and public disclosure for investor awareness.
Are RSUs referenced in the Ultragenyx (RARE) Form 4 for this insider?
The Form 4 states that her reported holdings include shares of common stock underlying previously granted RSUs. These restricted stock units are subject to vesting conditions, meaning some equity exposure is tied to future service or performance requirements.
AI-generated analysis. How Rhea-AI works. Not financial advice.
